| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 156, Issue 11 4290-4297, Copyright © 1996 by American Association of Immunologists
ARTICLES |
AK Bromander, L Ekman, M Kopf, JG Nedrud and NY Lycke
Department of Medical Microbiology and Immunology, University of Goteborg, Goteborg, Sweden.
Using IL-6-deficient (IL-6 -/-) or wild-type mice, we investigated whether IL-6 is involved in the intestinal adjuvant activity of cholera toxin (CT) and to what extent IL-6 is required for mucosal IgA responses against soluble protein Ags or live Helicobacter felis infection. In naive IL-6 -/- mice we found normal total IgA levels in serum, bronchial and intestinal lavage and unaltered frequencies of IgA plasma cells in intestinal lamina propria. In Peyer's patches (PP) and mesenteric lymph nodes (MLN) IgA-producing cells were as frequent in IL- 6 -/- as in wild-type mice. Immunohistochemical analysis of PP revealed germinal centers that co-localized IgA+ cells, indicating B cell activation and isotype switching in situ in the intestinal immune inductive site. Phenotypic analysis of the distribution of conventional B-2 cells (B220+CD5-/Mac-1-) and B-1 cells (B220+, CD5+/Mac-1+) in intestine-associated tissues gave comparable results in IL-6 -/- and wild-type mice. The ability to respond with mucosal IgA following oral and intranasal immunization with specific Ag, KLH or OVA, in the presence of CT adjuvant or to live H. felis infection was similar in IL- 6 -/- and wild-type mice. CT exerted strong and comparable adjuvant functions in IL-6 -/- and wild-type mice. Repeated oral immunizations with CT alone stimulated immune protection against CT-induced diarrhea in ligated loops that was of similar magnitude in IL-6 -/- and wild- type mice. We conclude that, although IL-6 has been ascribed a crucial role in terminal differentiation of IgA B cells in vitro, we found no evidence to support the notion that IL-6 is critically required for IgA B cell development or specific mucosal IgA responses in vivo.
This article has been cited by other articles:
|
|
 |
|
  S. M. Dann, M. E. Spehlmann, D. C. Hammond, M. Iimura, K. Hase, L. J. Choi, E. Hanson, and L. Eckmann IL-6-Dependent Mucosal Protection Prevents Establishment of a Microbial Niche for Attaching/Effacing Lesion-Forming Enteric Bacterial Pathogens J. Immunol., May 15, 2008; 180(10): 6816 - 6826. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Helgeby, N. C. Robson, A. M. Donachie, H. Beackock-Sharp, K. Lovgren, K. Schon, A. Mowat, and N. Y. Lycke The Combined CTA1-DD/ISCOM Adjuvant Vector Promotes Priming of Mucosal and Systemic Immunity to Incorporated Antigens by Specific Targeting of B Cells J. Immunol., March 15, 2006; 176(6): 3697 - 3706. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Sato, M. Hashiguchi, E. Toda, A. Iwasaki, S. Hachimura, and S. Kaminogawa CD11b+ Peyer's Patch Dendritic Cells Secrete IL-6 and Induce IgA Secretion from Naive B Cells J. Immunol., October 1, 2003; 171(7): 3684 - 3690. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Sait, M. Galic, R. A. Strugnell, and P. H. Janssen Secretory Antibodies Do Not Affect the Composition of the Bacterial Microbiota in the Terminal Ileum of 10-Week-Old Mice Appl. Envir. Microbiol., April 1, 2003; 69(4): 2100 - 2109. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Bienz, W. J. Dai, M. Welle, B. Gottstein, and N. Muller Interleukin-6-Deficient Mice Are Highly Susceptible to Giardia lamblia Infection but Exhibit Normal Intestinal Immunoglobulin A Responses against the Parasite Infect. Immun., March 1, 2003; 71(3): 1569 - 1573. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Q. Khan, Y. Shen, Z.-Q. Wu, T. A. Wynn, and C. M. Snapper Endogenous Pro- and Anti-Inflammatory Cytokines Differentially Regulate an In Vivo Humoral Response to Streptococcus pneumoniae Infect. Immun., February 1, 2002; 70(2): 749 - 761. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. De Benedetti, P. Pignatti, M. Vivarelli, C. Meazza, G. Ciliberto, R. Savino, and A. Martini In Vivo Neutralization of Human IL-6 (hIL-6) Achieved by Immunization of hIL-6-Transgenic Mice with a hIL-6 Receptor Antagonist J. Immunol., April 1, 2001; 166(7): 4334 - 4340. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. V. Solnick and D. B. Schauer Emergence of Diverse Helicobacter Species in the Pathogenesis of Gastric and Enterohepatic Diseases Clin. Microbiol. Rev., January 1, 2001; 14(1): 59 - 97. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Hiroi, M. Yanagita, N. Ohta, G. Sakaue, and H. Kiyono IL-15 and IL-15 Receptor Selectively Regulate Differentiation of Common Mucosal Immune System-Independent B-1 Cells for IgA Responses J. Immunol., October 15, 2000; 165(8): 4329 - 4337. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. VanCott, M. A. Franco, H. B. Greenberg, S. Sabbaj, B. Tang, R. Murray, and J. R. McGhee Protective Immunity to Rotavirus Shedding in the Absence of Interleukin-6: Th1 Cells and Immunoglobulin A Develop Normally J. Virol., June 1, 2000; 74(11): 5250 - 5256. [Abstract] [Full Text]
|
|
|
|
|
|
L. C. Agren, L. Ekman, B. Lowenadler, J. G. Nedrud, and N. Y. Lycke Adjuvanticity of the Cholera Toxin A1-Based Gene Fusion Protein, CTA1-DD, Is Critically Dependent on the ADP-Ribosyltransferase and Ig-Binding Activity J. Immunol., February 15, 1999; 162(4): 2432 - 2440. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Agren, M. Norin, N. Lycke, and B. Lowenadler Hydrophobicity engineering of cholera toxin A1 subunit in the strong adjuvant fusion protein CTA1-DD Protein Eng. Des. Sel., February 1, 1999; 12(2): 173 - 178. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. N. Boyaka, M. Marinaro, R. J. Jackson, S. Menon, H. Kiyono, E. Jirillo, and J. R. McGhee IL-12 Is an Effective Adjuvant for Induction of Mucosal Immunity J. Immunol., January 1, 1999; 162(1): 122 - 128. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Kopf, S. Herren, M. V. Wiles, M. B. Pepys, and M. H. Kosco-Vilbois Interleukin 6 Influences Germinal Center Development and Antibody Production via a Contribution of C3 Complement Component J. Exp. Med., November 16, 1998; 188(10): 1895 - 1906. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Itoh, K. Ishihara, T. Hiroi, B. Ok Lee, H. Maeda, H. Iijima, M. Yanagita, H. Kiyono, and T. Hirano Deletion of Bone Marrow Stromal Cell Antigen-1 (CD157) Gene Impaired Systemic Thymus Independent-2 Antigen-Induced IgG3 and Mucosal TD Antigen-Elicited IgA Responses J. Immunol., October 15, 1998; 161(8): 3974 - 3983. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. L. Perry, K. Feilzer, and H. D. Caldwell Neither Interleukin-6 nor Inducible Nitric Oxide Synthase Is Required for Clearance of Chlamydia trachomatis from the Murine Genital Tract Epithelium Infect. Immun., March 1, 1998; 66(3): 1265 - 1269. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
